Afatinib Dimaleate 20 Mg Australia

Afatinib Dimaleate 20 mg is an oral targeted therapy used to treat specific types of non-small cell lung cancer (NSCLC). It works by blocking EGFR signals that promote cancer cell growth and spread. It is usually taken once daily on an empty stomach, at least 1 hour before or 2 hours after a meal, preferably at the same time each day. Use exactly as directed by your healthcare professional. Active Ingredient (Generic Name): Afatinib Dimaleate Indication: Non-small cell lung cancer Manufacturer: Boehringer Ingelheim India Pvt.Ltd Packaging: 7 tablets in 1 strip Strength 20mg Delivery Time: 6 To 15 days